EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking

Luka Krstulović, Marijana Leventić, Vesna Rastija iD, Kristina Starčević, Maja Jirouš, Ivana Janić, Maja Karnaš iD, Kornelija Lasić, Miroslav Bajić, Ljubica Glavaš-Obrovac iD

Molecules · 2023

DOI: 10.3390/molecules28020540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Luka Krstulović und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Faculty of Veterinary Medicine, University of Zagreb, HR-10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Josip Juraj Strossmayer University of Osijek, Faculty of Medicine, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, new 7-chloro-4-aminoquinoline-benzimidazole compounds were synthesized and characterized by NMR, MS, and elemental analysis. These novel hybrids differ in the type of linker and in the substituent on the benzimidazole moiety. Their antiproliferative activities were evaluated on one non-tumor (MDCK1) and seven selected tumor (CaCo-2, MCF-7, CCRF-CEM, Hut78, THP-1, and Raji) cell lines by MTT test and flow cytometry analysis. The compounds with different types of linkers and an unsubstituted benzimidazole ring, 5d, 8d, and 12d, showed strong cytotoxic activity (the GI50 ranged from 0.4 to 8 µM) and effectively suppressed the cell cycle progression in the leukemia and lymphoma cells. After 24 h of treatment, compounds 5d and 12d induced the disruption of the mitochondrial membrane potential as well as apoptosis in HuT78 cells. The drug-like properties and bioavailability of the compounds were calculated using the Swiss ADME web tool, and a molecular docking study was performed on tyrosine-protein kinase c-Src (PDB: 3G6H). Compound 12d showed good solubility and permeability and bound to c-Src with an energy of −119.99 kcal/mol, forming hydrogen bonds with Glu310 and Asp404 in the active site and other residues with van der Waals interactions. The results suggest that compound 12d could be a leading compound in the further design of effective antitumor drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansMolecular StructureStructure-Activity RelationshipCell Line, TumorMolecular Docking SimulationCaco-2 CellsCell ProliferationBenzimidazolesDrug Screening Assays, AntitumorApoptosisAminoquinolines

Stichwörter der Autor:innen

aminoquinoline-benzimidazole hybridsanticancerapoptosiscell cycle perturbationdockingin silico ADMEmitochondrial membrane potential

Substanzen

Antineoplastic AgentsBenzimidazoles7-chloro-4-aminoquinolineAminoquinolines

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, Faculty of Veterinary Medicine, University of Zagreb, HR-10000 Zagreb, Croatia.
  • Department of Medicinal Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, HR-31000 Osijek, Croatia.
  • Department of Agroecology and Environmental Protection, Faculty of Agrobiotechnical Sciences Osijek, Josip Juraj Strossmayer University of Osijek, HR-31000 Osijek, Croatia.
  • R&D, Pliva Croatia Ltd., TEVA Group Member, HR-10000 Zagreb, Croatia.

ORCID-Profile: Vesna Rastija, Maja Karnaš, Ljubica Glavaš-Obrovac

Förderung

  • Josip Juraj Strossmayer University of Osijek, Faculty of Medicine
  • Faculty of Medicine, Josip Juraj Strossmayer University of Osijek

Zitieren

APA

Krstulović, L., Leventić, M., Rastija, V., Starčević, K., Jirouš, M., Janić, I., Karnaš, M., Lasić, K., Bajić, M., & Glavaš-Obrovac, L. (2023). Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking. Molecules. https://doi.org/10.3390/molecules28020540

Vancouver

Krstulović L, Leventić M, Rastija V, Starčević K, Jirouš M, Janić I, et al. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking. Molecules. 2023. doi:10.3390/molecules28020540

BibTeX
@article{Krstulovi2023,
  author = {Krstulović, Luka and Leventić, Marijana and Rastija, Vesna and Starčević, Kristina and Jirouš, Maja and Janić, Ivana and Karnaš, Maja and Lasić, Kornelija and Bajić, Miroslav and Glavaš-Obrovac, Ljubica},
  title = {Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28020540}
}
Kostenlos starten →